KURA - Kura Oncology, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
San Diego,
United States
Type: Equity
KURA price evolution
KURA
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $45.18 | $41.51 | $37.32 | |
| Short term investments | $446.34 | $485.62 | $386.64 | |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $463.19 | $499.77 | $537.84 | $432.48 |
| Long term investments | ||||
| Property, plant & equipment | $7.42 | $7.92 | $8.41 | $8.85 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $15.35 | $16.07 | $16.45 | |
| Total investments | $446.34 | $485.62 | $386.64 | |
| Total assets | $478.84 | $515.12 | $553.91 | $448.94 |
| Current liabilities | ||||
| Accounts payable | $3.01 | $31.14 | $30.9 | $33.76 |
| Deferred revenue | ||||
| Short long term debt | $2.31 | $1.36 | $1.51 | |
| Total current liabilities | $40.37 | $33.45 | $32.27 | $35.26 |
| Long term debt | $7.76 | $14.42 | $15.61 | $15.69 |
| Total noncurrent liabilities | $15.6 | $16.56 | $16.4 | |
| Total debt | $16.73 | $16.97 | $17.2 | |
| Total liabilities | $55.07 | $49.05 | $48.82 | $51.66 |
| Shareholders' equity | ||||
| Retained earnings | -$876.21 | -$821.8 | -$770.96 | -$721.44 |
| Other shareholder equity | $1.12 | -$0.46 | -$0.82 | -$1.27 |
| Total shareholder equity | $466.07 | $505.08 | $397.27 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $37.32 | $52.01 | $90.88 | $325.7 |
| Short term investments | $386.64 | $386.18 | $427.29 | $307.83 |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $432.48 | $446.43 | $522.29 | $637.29 |
| Long term investments | ||||
| Property, plant & equipment | $8.85 | $6.38 | $8.25 | $8.36 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $16.45 | $9.88 | $11.76 | $9.92 |
| Total investments | $386.64 | $386.18 | $427.29 | $307.83 |
| Total assets | $448.94 | $456.31 | $534.05 | $647.21 |
| Current liabilities | ||||
| Accounts payable | $33.76 | $1.53 | $22.45 | $23.02 |
| Deferred revenue | ||||
| Short long term debt | $1.51 | $2.32 | $3 | |
| Total current liabilities | $35.26 | $24.06 | $22.45 | $26.02 |
| Long term debt | $15.69 | $9.16 | $4.61 | $9.89 |
| Total noncurrent liabilities | $16.4 | $11.97 | $4.99 | $10.28 |
| Total debt | $17.2 | $14.02 | $4.61 | $12.89 |
| Total liabilities | $51.66 | $36.03 | $27.44 | $36.31 |
| Shareholders' equity | ||||
| Retained earnings | -$721.44 | -$568.81 | -$432.97 | -$302.5 |
| Other shareholder equity | -$1.27 | -$8.03 | -$1.79 | $0.05 |
| Total shareholder equity | $397.27 | $420.28 | $506.61 | $610.9 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $39.73 | $36.27 | $32.53 | |
| Selling, general & administrative | $16.68 | $18.18 | $14.23 | |
| Total operating expenses | $59.88 | $56.4 | $54.45 | $46.76 |
| Operating income | -$56.4 | -$54.45 | -$46.76 | |
| Income from continuing operations | ||||
| EBIT | -$50.43 | -$49.13 | -$42.39 | |
| Income tax expense | ||||
| Interest expense | $5.48 | $0.41 | $0.4 | $0.39 |
| Net income | ||||
| Net income | -$54.4 | -$50.84 | -$49.52 | -$42.79 |
| Income (for common shares) | -$50.84 | -$49.52 | -$42.79 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $115.23 | $92.81 | $84.72 | $60.4 |
| Selling, general & administrative | $50.57 | $47.05 | $46.54 | $31.5 |
| Total operating expenses | $165.8 | $139.87 | $131.26 | $91.9 |
| Operating income | -$165.8 | -$139.87 | -$131.26 | -$91.9 |
| Income from continuing operations | ||||
| EBIT | -$151.08 | -$135.61 | -$130.05 | -$89.05 |
| Income tax expense | ||||
| Interest expense | $1.55 | $0.23 | $0.41 | $0.58 |
| Net income | ||||
| Net income | -$152.63 | -$135.84 | -$130.47 | -$89.63 |
| Income (for common shares) | -$152.63 | -$135.84 | -$130.47 | -$89.63 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$50.84 | -$49.52 | -$42.79 | |
| Operating activities | ||||
| Depreciation | $0.2 | $0.23 | $0.21 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $8.43 | $8.51 | $7.17 | |
| Total cash flows from operations | -$42.53 | -$48.84 | -$34.31 | |
| Investing activities | ||||
| Capital expenditures | -$0.02 | -$0.08 | -$0.02 | |
| Investments | $43.18 | -$95.25 | $42.21 | |
| Total cash flows from investing | -$6.63 | $43.17 | -$95.34 | $42.2 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $3.04 | $148.37 | $0.69 | |
| Net borrowings | ||||
| Total cash flows from financing | $153.61 | $3.04 | $148.37 | $0.69 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $12.16 | $3.68 | $4.19 | $8.58 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$152.63 | -$135.84 | -$130.47 | -$89.63 |
| Operating activities | ||||
| Depreciation | $0.85 | $0.76 | $0.56 | $0.19 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $28.08 | $26.32 | $23.58 | $12.81 |
| Total cash flows from operations | -$124.82 | -$110.06 | -$104.55 | -$69.83 |
| Investing activities | ||||
| Capital expenditures | -$0.17 | -$0.63 | -$1.15 | -$2.17 |
| Investments | $15.72 | $33.25 | -$125.69 | -$97.77 |
| Total cash flows from investing | $15.56 | $32.63 | -$126.83 | -$99.94 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $94.78 | $29.14 | $4.43 | $469.58 |
| Net borrowings | $9.43 | -$7.86 | -$0.25 | |
| Total cash flows from financing | $94.78 | $38.56 | -$3.44 | $469.33 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$14.48 | -$38.87 | -$234.82 | $299.57 |
News
Fundamentals
| Market cap | $437.73M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 77.75M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$197.55M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -2.22 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$2.54 |
|---|---|
| ROA | -39.57% |
| ROE | N/A |
| Debt/Equity | 0.13 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 11.47 |
| Quick ratio | N/A |